Catalyst Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Catalyst Biosciences, Inc.‘s stocks are currently a part of 21 hedge funds’ portfolios, which represents 6.74% of the total amount of its stocks outstanding. This makes up a total of 2.12M shares of Catalyst Biosciences, Inc.. Compared to the previous quarter, the number fell by -57.46% or -2.86M shares fewer. As for the holding position changes, 23.81% (5) of current hedge fund investors increased the number of shares held, 9.52% (2) of current holders sold a part of the shares held, and 9.52% (2) closed the holdings completely. 7 hedge funds are new holders of Catalyst Biosciences, Inc. stock in Q1 2023, it is 33.33% of total holders.
Hedge funds holding Catalyst Biosciences (Q2 2018 – Q1 2023)
| Q2 2018 | 72 |
|---|---|
| Q3 2018 | 69 |
| Q4 2018 | 65 |
| Q1 2019 | 62 |
| Q2 2019 | 48 |
| Q3 2019 | 40 |
| Q4 2019 | 45 |
| Q1 2020 | 45 |
| Q2 2020 | 79 |
| Q3 2020 | 76 |
| Q4 2020 | 79 |
| Q1 2021 | 86 |
| Q2 2021 | 68 |
| Q3 2021 | 65 |
| Q4 2021 | 49 |
| Q1 2022 | 40 |
| Q2 2022 | 38 |
| Q3 2022 | 33 |
| Q4 2022 | 32 |
| Q1 2023 | 21 |
Hedge funds changes in Catalyst Biosciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 38 | 23 | 8 | 19 | -16 |
|---|---|---|---|---|---|
| Q3 2018 | 14 | 30 | 15 | 17 | -7 |
| Q4 2018 | 11 | 24 | 20 | 14 | -4 |
| Q1 2019 | 7 | 22 | 23 | 10 | 0 |
| Q2 2019 | 11 | 19 | 16 | 23 | -21 |
| Q3 2019 | 6 | 11 | 15 | 14 | -6 |
| Q4 2019 | 11 | 11 | 17 | 7 | -1 |
| Q1 2020 | 12 | 17 | 10 | 12 | -6 |
| Q2 2020 | 36 | 21 | 16 | 2 | 4 |
| Q3 2020 | 8 | 33 | 19 | 11 | 5 |
| Q4 2020 | 18 | 30 | 18 | 13 | 0 |
| Q1 2021 | 18 | 39 | 18 | 11 | 0 |
| Q2 2021 | 10 | 18 | 29 | 28 | -17 |
| Q3 2021 | 14 | 9 | 31 | 15 | -4 |
| Q4 2021 | 12 | 11 | 14 | 28 | -16 |
| Q1 2022 | 2 | 7 | 16 | 12 | 3 |
| Q2 2022 | 8 | 3 | 14 | 10 | 3 |
| Q3 2022 | 3 | 8 | 8 | 8 | 6 |
| Q4 2022 | 7 | 8 | 12 | 7 | -2 |
| Q1 2023 | 7 | 5 | 2 | 2 | 5 |
Hedge funds changes in Catalyst Biosciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 3,755,000 | 4,163,000 |
|---|---|---|
| Q3 2018 | 679,000 | 3,409,000 |
| Q4 2018 | 554,000 | 401,000 |
| Q1 2019 | 598,000 | 504,000 |
| Q2 2019 | 196,000 | 118,000 |
| Q3 2019 | 15,000 | 30,000 |
| Q4 2019 | 117,000 | 78,000 |
| Q1 2020 | 492,000 | 445,000 |
| Q2 2020 | 875,000 | 544,000 |
| Q3 2020 | 309,000 | 4,000 |
| Q4 2020 | 1,881,000 | 76,000 |
| Q1 2021 | 2,922,000 | 577,000 |
| Q2 2021 | 1,849,000 | 43,000 |
| Q3 2021 | 5,109,000 | 84,000 |
| Q4 2021 | 435,000 | 0 |
| Q1 2022 | 165,000 | 0 |
| Q2 2022 | 6,668,000 | 27,000 |
| Q3 2022 | 1,298,000 | 2,000 |
| Q4 2022 | 173,488 | 211 |
| Q1 2023 | 14,588,000 | 0 |